ArticleTropical medicine and health2021
Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward.
Article in Tropical medicine and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 35 citations in OpenAlex.
- Association Between Erectile Dysfunction and Lower Urinary Tract Symptoms in a North Indian Tertiary Care Hospital.Cureus · 2025Article
- Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.BMC health services research · 2024Article
- The impact of COVID-19 on tuberculosis in most populated state of India: A geospatial meta-analysis.Journal of family medicine and primary care · 2024Review
- Pathophysiological, immunological, and inflammatory features of long COVID.Frontiers in immunology · 2024Review
- Assessing the impact of the COVID-19 pandemic on neglected tropical diseases in India: a perspective.Frontiers in public health · 2024Review
- The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.PLOS global public health · 2024Article
- Lessons for TB from the COVID-19 response: qualitative data from Brazil, India and South Africa.Public health action · 2023Article
- Article
- Global-, Regional-, and National-Level Impacts of the COVID-19 Pandemic on Tuberculosis Diagnoses, 2020-2021.Microorganisms · 2023Article
- Proposed Algorithm for Integrated Management of TB-SARS-CoV-2 Co-Infection in a TB-Endemic Country.Tropical medicine and infectious disease · 2022Article
- Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China.BMC infectious diseases · 2022Article
- Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.BMC public health · 2022Article
- HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.Epidemiology and infection · 2022Article
- Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.Epidemiology and infection · 2022Article
- The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini.International journal of public health · 2022Article
- Pathogenesis of SARS-CoV-2 andFrontiers in immunology · 2022Review
- Tuberculosis in the middle of COVID-19 in Morocco: efforts, challenges and recommendations.Tropical medicine and health · 2021Article
- COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.Clinical epidemiology and global healthArticle
- The Effect of COVID-19 on Tuberculosis Care and Treatment Outcome in Pre-COVID, COVID, and Post-COVID Eras.Indian journal of community medicine : official publication of Indian Association of Preventive & Social MedicineArticle
- Innovations triggered by India's bold vision to end tuberculosis.The Indian journal of medical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 6 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India is home to the most significant number of tuberculosis (TB) cases around the globe. The COVID-19 crisis has deeply perturbed most of the essential TB services in India. Regulating TB is difficult in a densely populated country like India due to latent TB infection in millions of Indians, which can reactivate at any point in the future. Due to the ongoing pandemic, healthcare workers have been diverted to activities implemented for effective COVID-19 management, leaving a meager workforce to help deal with TB management. Integrating TB and COVID-19 to augment India's health outreach is the need of the hour to diminish the effect of the COVID-19 crisis on TB. Increasing overall testing capacity, active screening, implementation of strategies for easy identification of TB hotspots, and ensuring uninterrupted drug supply for treatment through heedful planning of local and regional distribution and transportation will especially help cater to the vulnerable population who are at a high risk of suffering from adverse outcomes of TB. Lessons learnt in the battle against COVID-19 can most definitely help in providing insights to fulfill the goal of eliminating TB from India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.